The RADAR-base platform, developed as part of RADAR-CNS, is now being used to study patients with atrial fibrillation (AF).
The University of Birmingham, which is a project partner in the BigData@Heart consortium, is conducting a year-long study as part of the follow-up phase of the RAte control Therapy Evaluation in permanent Atrial Fibrillation (RATE-AF) trial.
Read more...